Key trial test begins for plasma-based COVID-19 therapy from Takeda, CSL

This week, a network of roughly five dozen hospitals and clinics spread across five continents began enrolling patients hospitalized with COVID-19 into a randomized and placebo-controlled study aimed at better answering whether a concentrated solution of blood antibodies can help treat the coronavirus disease.